Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Karuna Therapeutics, Inc. (KRTX)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 40,277,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Karuna Therapeutics is a clinical-stage biopharmaceutical company that focuses on transformative medicines for people living with psychiatric and neurological conditions. Co.'s proprietary product candidate, KarXT (xanomeline-trospium), an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. KarXT combines xanomeline, a muscarinic agonist, with trospium, an approved muscarinic antagonist, to preferentially stimulate muscarinic receptors in the CNS. Co. is developing KarXT for the treatment of psychosis in adults with schizophrenia as well as for the treatment of psychosis in Alzheimer's disease.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 120,000
Total Buy Value $0 $0 $0 $14,736,159
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 2
Total Shares Sold 10,000 40,000 107,929 348,973
Total Sell Value $3,172,380 $10,837,466 $24,302,893 $74,283,009
Total People Sold 1 1 4 6
Total Sell Transactions 2 5 14 44
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 347
  Page 10 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Preston Heather Director   –       •      –    2021-03-08 4 A $0.00 $0 D/D 572 6,372     -
   Pande Atul   –       •      –    2021-03-01 4 AS $125.43 $313,575 D/D (2,500) 0     -
   Pande Atul   –       •      –    2021-03-01 4 OE $16.00 $40,000 D/D 2,500 2,500     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2021-02-16 4 AS $119.57 $1,195,700 D/D (10,000) 13,000     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2021-02-16 4 OE $9.20 $92,000 D/D 10,000 23,000     -
   Miller Andrew Craig Chief Operating Officer   •       –      –    2021-02-10 4 AS $114.06 $570,300 D/D (5,000) 45,500     -
   Miller Andrew Craig Chief Operating Officer   •       –      –    2021-02-10 4 OE $9.20 $46,000 D/D 5,000 50,500     -
   Puretech Health Llc Former 10% Owner   –       –      –    2021-02-09 4 S $118.00 $118,000,000 D/D (1,000,000) 2,406,564     -
   Pande Atul   –       •      –    2021-02-01 4 AS $100.00 $250,000 D/D (2,500) 0     -
   Pande Atul   –       •      –    2021-02-01 4 OE $16.00 $40,000 D/D 2,500 2,500     -
   Miller Andrew Craig Chief Operating Officer   •       –      –    2021-01-11 4 AS $105.11 $525,550 D/D (5,000) 45,500     -
   Miller Andrew Craig Chief Operating Officer   •       –      –    2021-01-11 4 OE $7.27 $39,106 D/D 5,000 46,928     -
   Nelsen Robert Director   –       •       •   2021-01-08 4 A $0.00 $0 D/D 1,756 3,513     -
   Nelsen Robert Director   –       •       •   2021-01-08 4 D $0.00 $0 I/I (150,000) 1,531,435     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2021-01-08 4 AS $104.49 $835,920 D/D (8,000) 13,000     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2021-01-08 4 OE $9.20 $73,600 D/D 8,000 21,000     -
   Crandell Keith 10% Owner   –       –       •   2021-01-08 4 A $0.00 $0 D/D 1,264 612     -
   Crandell Keith 10% Owner   –       –       •   2021-01-08 4 D $0.00 $0 I/I (150,000) 1,531,435     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2020-12-29 4 OE $9.20 $73,600 D/D 8,000 13,000     -
   Pande Atul   –       •      –    2020-12-14 4 AS $92.64 $529,345 D/D (5,714) 0     -
   Pande Atul   –       •      –    2020-12-14 4 OE $2.92 $16,685 D/D 5,714 5,714     -
   Miller Andrew Craig Chief Operating Officer   •       –      –    2020-12-14 4 OE $2.92 $36,500 D/D 12,500 45,500     -
   Miller Andrew Craig Chief Operating Officer   •       –      –    2020-12-10 4 AS $94.82 $474,100 D/D (5,000) 45,500     -
   Miller Andrew Craig Chief Operating Officer   •       –      –    2020-12-10 4 OE $7.27 $39,108 D/D 5,000 46,929     -
   Crandell Keith 10% Owner   –       –       •   2020-11-12 4 A $0.00 $0 D/D 1,264 306     -

  347 Records found
  Previous  10  11  12  13  14   
  Page 10 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed